Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Fibril clearance antibodies, SAP depletion, and cardiac remodeling approaches in the ATTR cardiac amyloidosis drug pipeline — patent signals and clinical evidence.
Article | Report Explore the 2026 photonic QKD technology landscape: key protocols, distance records, chip-scale integration, and strategic IP implications from 20+ years of patent data.
Article | Report Photonic QKD has reached 658 km fiber range and 1 Gbit/s key rates. Explore the 2026 technology landscape: protocols, chip integration, and IP white spaces.
Article | Report Burosumab expansion, FGF23 pathway inhibitors, and phosphate metabolism approaches shaping the XLH drug pipeline. Evidence from patents and clinical trials.
Article | Report Explore the 2026 electrochemical levulinic acid technology landscape: key patents, ECH benchmarks, assignee gaps, and emerging paired electrolysis directions.
Article | Report Explore the MCI prevention drug pipeline: BDNF/TrkB signaling, synaptic plasticity, NMDA receptor modulators, and multi-modal approaches targeting pre-dementia cognitive decline.
Article | Report A 2026 patent landscape analysis of plasma ozone generation: DBD reactors, AI-controlled systems, plasma vortex, UV-photocatalytic hybrids, and key assignees across Japan, Korea, and Europe.
Article | Report Explore the skin aging and photoaging drug pipeline: senolytic topicals, collagen biosynthesis stimulators, and next-generation retinoid approaches. Patent and clinical signals analysed.
Article | Report QD-EL device landscape 2026: EQE benchmarks hit 28.7% green, 21.9% blue. Explore patent clusters, assignee data, and emerging directions in QLED technology.
Article | Report Survey of the 2026 low-loss dielectric materials landscape for 5G and 6G: polymer substrates, ceramic composites, nano-structures, and key institutional innovators.
Article | Report How the NLRP3 inflammasome and IL-6/STAT3 axis are driving a new wave of anti-inflammaging drug development — from MCC950 to senolytics and metabolic repurposing.
Article | Report How statistical shape modeling improves dimensional inspection planning for complex freeform aerospace components — adaptive sampling, deviation prediction, and DFI frameworks.
Article | Report How SOEC co-electrolysis and eCO₂R are reshaping syngas production: efficiency data, assignee landscape, application domains, and strategic IP implications for 2026.
Article | Report Layered oxides and Prussian blue analogues for sodium-ion batteries: structural archetypes, entropy engineering, key IP players, and commercialisation signals for 2026.
Article | Report Beyond lithium and valproate: how glutamatergic, neuroinflammatory, and circadian clock mechanisms are reshaping the bipolar disorder drug pipeline.